Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) NSE

172.20

+2.72(+1.60%)

Updated at September 08 01:03PM

Currency In INR

Valuation

Market Cap3B
Enterprise Value3.33B
P/E Ratio7.71
PEG Ratio0.75
Price/Sales Ratio0.81
Price/Book Ratio0.51
Enterprise/Revenue0.89
Enterprise/EBITDA6.75

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.11
Operating Margin0.12

Management Effectiveness

Return On Assets0.04
Return On Equity0.07

Income Statement

Revenue3.65B
Revenue/Share212.57
Gross Profit2.29B
EBITDA497.98M
Net Income386M
Diluted EPS19.86

Balance Sheet

Total Cash888.99M
Total Cash/Share46.69
Total Debt1.23B
Total Debt/Equity0.19
Current Ratio1.89
Book Value Per Share338.43

Price History

52-Week Change-19.61
52-Week High238.69
52-Week Low137.55
Moving Average 50 Days188.9
Moving Average 200 Days178.19

Statistics

Average Volume39,386
Shares Outstanding19M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate2
Trailing Annual Dividend Yield1.16
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A